Bharat Rasayan Ltd has informed BSE about : <BR><BR>1. Standalone Financial Results for the period ended December 31, 2025<BR><BR>2. Consolidated Financial Results for the period ended ....
BHARATRAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Rasayan reported Q3 FY26 standalone revenue from operations of ₹270.46 crore, up ~5.5% from ₹256.40 crore in Q3 FY25. Nine-month revenue grew ~7.8% to ₹933.82 crore. Standalone Q3 PAT rose ~14.5% YoY to ₹33.99 crore, while 9M PAT grew ~7.4% to ₹103.81 crore. Operating margin expanded to 17.25% in Q3 (vs 16.63%) and 16.85% for 9M (vs 15.74%), supported by lower raw material costs. Consolidated Q3 PAT was higher at ₹40.03 crore (boosted by ₹6.04 crore share of joint venture profit), though 9M consolidated PAT declined ~7% YoY to ₹107.57 crore due to exceptional items. The company also completed a 1:1 bonus issue and share split (₹10 to ₹5 face value) during the quarter, restating EPS for prior periods.
Margin expansion and steady revenue growth are positive signals, though the presence of exceptional items worth ₹13.29 crore in 9M FY26 (linked to Dahej plant insurance matters) dragged consolidated bottom-line growth. Credit rating reaffirmed at CARE AA-/A1+ and very low debt-equity (0.07x) suggest a stable financial profile for shareholders.